The administration of the Society is carried out by the Board of Directors.
The Board of Directors consists of:
I. the Steering Committee,
II. the Executive Board, which includes ex-officio everyone who held the title of the President MiECTiS,
III. the Secretary of the forthcoming MiECT Symposium,
IV. all prime investigators of the multicentre trial, for the period that it is conducted.
The MiECT update Meeting is institutionalized.
I. The “MiECT update Meeting” is a scientific Congress that is under the auspices of the Association, and represents, along with the “MiECT Symposium“, the major events of the Society.
II. The “MiECT update Meeting” takes place every two (2) years, alternate to “MiECT Symposium“, in the Seat of the Association, Thessaloniki, Greece.
III. The President of the “MiECT update Meeting” is the most senior local member of the Association.
IV. The “MiECT update Meeting” takes place during the first weeks of December.
V. The President of “MiECT update Meeting” is fully responsible for the finances of the Meeting that is sponsored by the industry. There is no involvement of the Association by any means in financial issues.
VI. Participants at “MiECT update Meeting” are:
a. the President (1) of “MiECT update Meeting”,
b. the members (7) of MiECTiS Steering Committee,
c. seven (7) investigators presenting Best Innovative recent Work in the field of MiECT,
d. six (6) members from the industry presenting technological advances.
VII. The “MiECT update Meeting” will be open for all MiECTiS members with no registration fees.
VIII. The “MiECT update Meeting” preferably has the form of a webinar with free online access to all MiECTiS members.
MiECTiS General Assembly